Monte Rosa Therapeutics
GLUE
#6712
Rank
S$0.95 B
Marketcap
S$11.15
Share price
-3.03%
Change (1 day)
-39.98%
Change (1 year)

Earnings for Monte Rosa Therapeutics (GLUE)

Earnings in 2026 (TTM): -S$0.17 Billion

According to Monte Rosa Therapeutics's latest financial reports the company's current earnings are S$70.32 Million. In 2025 the company made an earning of -S$51.25 Million, an increase over its 2024 earnings that were of -S$90.47 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Monte Rosa Therapeutics from 2020 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$0.17 Billion226.51%
2025 -S$51.25 Million-43.36%
2024 -S$90.47 Million-48.06%
2023 -S$0.18 Billion24.43%
2022 -S$0.14 Billion46.71%
2021 -S$95.41 Million106.13%
2020 -S$46.29 Million